Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs ReadyRx

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and ReadyRx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 222 · Grade C

ReadyRx

Visit ReadyRx Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 67 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make ReadyRx a bad call — it's best for readers comparing online glp-1 care who will confirm the chosen monthly or quarterly offer and request the full cancellation agreement. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
75
Transparency
90
48
Access Breadth
93
90
Clinical Oversight
92
79
Track Record
88
73
CoreAge RxBrief Score 94 · 67ReadyRx

Price, coverage & the tracker

CoreAge RxReadyRx
Brief Score94/100 (A)67/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm the selected plan

Monthly table: $229 first month, then $249/month. Hero advertises from $179 with a separate plan selection.

Confirm the complete term, supplied quantity and cancellation agreement.

Full price details

Current selected compounded semaglutide plan quote unknown; rendered monthly table shows $229 first month then $249/month, while hero starts at $179; earlier listing: From $179/mo (starting dose, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm the selected plan

Monthly table: $295 first month, then $315/month. Hero advertises from $255 with a separate plan selection.

Confirm the complete term, supplied quantity and cancellation agreement.

Full price details

Current selected compounded tirzepatide plan quote unknown; rendered monthly table shows $295 first month then $315/month, while hero starts at $255; earlier listing: From $255/mo (starting dose, compounded)

CoverageUS only; restrictions by state, confirmed at intakeConfirm treatment eligibility for your physical location; a current medication-specific state list was not established
Brand-name accessNot confirmedNamed Ozempic and Zepbound cards link to separate advertised treatment paths; current eligibility, complete brand-plan quote and pharmacy require confirmation.
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

ReadyRx: Monthly table: semaglutide $229 first month then $249; tirzepatide $295 then $315. Lower hero starts should not be assumed to price the same selection.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.